Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting

Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting

Rosaria Di Lorenzo,1 Paola Ferri,2 Michela Cameli,3 Sergio Rovesti,4 Chiara Piemonte5 1Psychiatric Intensive Treatment Facility, Department of Mental Health and Drug Abuse, AUSL Modena, Modena, Italy; 2Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Di Lorenzo R, Ferri P, Cameli M, Rovesti S, Piemonte C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Paliperidone Palmitate once-monthly Haloperidol decanoate Aripiprazole prolonged release once-monthly Schizophrenia relapses and clinical course Long-acting treatment effectiveness. First generation antipsychotics Second generation antipsychotics
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/f989c6af8c7f4cfc85e9bc8165ab097f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f989c6af8c7f4cfc85e9bc8165ab097f

Ejemplares similares